Regulatory Affairs
FDA, EMA, and global regulatory strategy across pharma, biotech, and medical devices.
FDA Regulatory Consulting
EU MDR & Regulatory Strategy
Submissions Management
Regulatory Intelligence
Pharmaceutical·Biotech·Medical Device·Cell & Gene Therapy·IVD·Digital HealthMedical Device·Pharma·Biotech
Regulatory & Quality Leadership
Embedded in Your Team.
Skip the hiring process. Deploy experienced regulatory and quality professionals without the cost or commitment of a full-time hire.
SERVICES
Regulatory & Quality Expertise, On Demand.
Senior-level regulatory and quality expertise, embedded in your team.
Quality & Compliance
Quality systems that satisfy regulators and protect patients.
GxP Compliance & Auditing
Inspection Readiness
QMS Implementation
ISO 13485 & ISO 14971
HOW WE WORK
Three Ways to Engage
Whether you need ongoing embedded leadership, a defined project delivered, or strategic advisory support: we have a model that fits where you are.
Fractional Leadership
A senior regulatory or quality expert integrates directly into your team as your de facto Head of Regulatory or Head of Quality, owning strategy, leading submissions, engaging regulators, and building your function while you scale.
- Regulatory or quality strategy ownership
- FDA, EMA, and Notified Body engagement
- Cross-functional team leadership
- Smooth handoff to your full-time hire
Project-Based Consulting
Specific regulatory and quality deliverables executed end-to-end by a senior consultant. Each engagement begins with a scoping phase to lock deliverables, timeline, and price before any work begins. No hourly billing surprises.
- Regulatory submissions
- QMS builds, audits, and remediation
- ISO 13485, ISO 14971, and GxP compliance
- Fixed deliverables, fixed price
Strategic Advisory
Senior regulatory and quality counsel for critical decisions, regulatory strategy reviews, agency meeting preparation, due diligence support, or board-level regulatory briefings.
- Regulatory strategy development
- Agency meeting preparation and briefing
- M&A regulatory due diligence
- Executive and board-level briefings
Every engagement is led by a senior practitioner with direct experience at FDA, Big Pharma, and global life sciences organizations — not junior consultants or project managers.
INDUSTRIES
Built for the Full Spectrum of Life Sciences
PharmaceuticalPharma
BiotechnologyBiotech
Medical Devices
In Vitro DiagnosticsIVD
Cell & Gene Therapy
Digital Health & SaMDDigital Health
THERAPEUTIC AREAS
Deep Expertise Across Therapeutic Areas
Our consultants bring direct experience in the disease areas your products address, not just the regulatory frameworks around them.
Oncology
Immunology & Inflammation
Rare Disease & Orphan Drugs
Cell & Gene Therapy
Hematology
Neuroscience & CNS
Infectious Disease & Vaccines
Cardiovascular
Endocrinology & Metabolic Disease
Respiratory & Pulmonology
Medical Devices & Diagnostics
Digital Health & SaMD
Women's Health
Dermatology
Ophthalmology
Microbiome & Novel Modalities
INSIGHTS
Regulatory Intelligence & Industry Insights
Expert perspectives on the evolving regulatory landscape, written by senior practitioners who work in it every day.
FDA Guidance
What FDA's 2026 Restructuring Means for Your IND Submission Timeline
Read the ArticleEU MDR & IVDR
Post-Market Surveillance Under EU MDR: What Device Companies Are Still Getting Wrong
Read the ArticleICH Q Standards
ICH Q12 Lifecycle Management: Are You Using It Strategically or Just Complying With It?
Read the ArticleSELECTED ENGAGEMENTS
Real Work. Real Outcomes.
A representative sample of engagements delivered by our consultants across pharmaceutical, biotech, medical device, IVD, and combination product programs.
Johnson & Johnson
Regulatory Lead, Global Orthopaedics Special Projects
Three years as FDA and EU MDR regulatory lead for thirty supplier-transfer cost-improvement projects across the orthopaedics portfolio. Owned regulatory impact assessments, Tech File updates, labeling remediation, and reporting to the executive team.
ARKRAY USA
Regulatory & Quality PM · Six IVD Launches
Led all regulatory and quality deliverables across six in-vitro diagnostic product launches, including innovative diabetes management systems and blood analyzers. Built the Risk Management File for each and drove ISO 13485:2016 QMS implementation across the organization.
ProPlate
Quality Lead · Notified Body Audit Rescue
Brought in after the Quality Manager exited weeks before the ISO 13485 notified body audit. Closed open CAPAs, remediated ISO 14971 gaps, executed an internal audit, and supported the organization through the audit itself.
ABOUT
About Regulatory Leadership Partners
Regulatory Leadership Partners is a specialized life sciences consulting firm that deploys senior regulatory and quality experts as embedded fractional leaders. We serve pharmaceutical, biotech, medical device, IVD, and cell and gene therapy organizations at every stage of the product lifecycle, from first regulatory strategy through post-market compliance.
Our experts integrate directly into client teams — owning strategy, leading submissions, building quality systems, and engaging regulatory authorities on your behalf. You get VP-level regulatory and quality leadership, on demand, without the overhead of a full-time executive hire.
“We needed someone who could walk into FDA and speak the same language — and that’s exactly what we got. The work was done at a level I’d expect from someone who’s been doing this for 25 years.”
— VP of Regulatory Affairs, Top-10 Medical Device Manufacturer
Strategic
We align regulatory and quality strategy with your business objectives from day one, not just compliance checkboxes.
Embedded
Our experts integrate into your team, your tools, and your workflows, functioning as your in-house regulatory and quality leadership.
Accountable
We own outcomes, not just deliverables. Your path to market is our mission.
CONTACT
Ready to Talk?
Tell us about your regulatory challenge. We will match you with the right expert and respond within one business day. All inquiries are strictly confidential.